MétaCan
Menu
Back to cohort
Record W7116968462 · doi:10.1177/17562848251403009

Effectiveness of ustekinumab in Crohn’s disease across intestinal locations: spotlight on isolated small intestinal involvement

2025· article· en· W7116968462 on OpenAlexaboutno aff
Yue Yu, Shuyan Li, Hanwen Chen, Yan Chen

Bibliographic record

VenueTherapeutic Advances in Gastroenterology · 2025
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicInflammatory Bowel Disease
Canadian institutionsnot available
FundersDepartment of Education of Zhejiang Province
KeywordsUstekinumabDiseaseCrohn's diseaseInflammatory bowel diseaseIntestinal mucosa

Abstract

fetched live from OpenAlex

Background: Small intestinal-predominant Crohn's disease (CD) exhibits distinct therapeutic patterns and is characterized by increased biological use and intestinal resection rates. However, systematic evaluations of the objective response of ustekinumab (UST), particularly related to disease location, are limited. Objectives: To compare the therapeutic efficacy of UST between small intestinal CD (SICD) and non-small intestinal CD (NSICD). Design: A prospective observational cohort study. Methods: Demographic and clinical characteristics were collected at baseline and 52-week follow-up, assessments including endoscopy, imaging, ultrasonography (US), histopathology, fecal calprotectin (FCP), C-reactive protein (CRP), and hemoglobin results. Patients with isolated ileal involvement (Montreal classification L1) were classified as having SICD, while NSICD was defined by L2 and L3. Primary outcome was objective remission, defined by meeting one of the following: (1) endoscopic remission (ER): Simple endoscopic score for CD (SES-CD) ⩽ 2. (2) US remission: normal bowel wall thickness and absence of Doppler signals or detectable complications, or (3) radiological remission: complete resolution of inflammatory features. Secondary outcomes included (1) mucosal healing (MH): absence of ulcerations. (2) transmural healing (TH): complete healing of all intestinal wall layers, and (3) biochemical remission: FCP/CRP normalization, (4) objective response: a clear improvement from baseline, and (5) endoscopic response: SES-CD ⩽ 4. Results: This study included 331 patients with CD (SICD 36.9%, NSICD 63.1%). Of these, 309 completed a 52-week follow-up. Objective remission, MH, and TH were achieved by 32.7%, 25.6%, and 13.6% of patients, respectively. Biochemical remission occurred in 41.5% (FCP) and 35.2% (CRP). Objective and endoscopic responses were observed in 70.2% and 42.1% of patients, respectively. Objective remission was achieved in 54/116 patients (46.6%) in the SICD group and 47/193 (24.4%) in the NSICD group. Regression analyses and propensity score matching showed significantly higher rates of objective remission, MH, and endoscopic response in the SICD group. Conclusion: Disease location influenced UST treatment outcomes, with SICD showing higher rates of objective remission, MH, and endoscopic response than NSICD.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.043
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.008
GPT teacher head0.284
Teacher spread0.276 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueTherapeutic Advances in GastroenterologySame topicInflammatory Bowel DiseaseFrench-language works237,207